REPL Replimune Group Forecast, Technical & Fundamental Analysis

a developer of oncolytic immunotherapies

Industry Biotechnology

Get AI intraday signals

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REPL
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REPL
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

REPL is expected to report earnings to rise 7.05% to -83 cents per share on November 05

Replimune Group REPL Stock Earnings Reports

Q3'24

Est.

$-0.83

Q2'24

Beat

by $0.08

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.12

Q3'23

Missed

by $0.09

The last earnings report on August 08 showed earnings per share of -77 cents, beating the estimate of -85 cents. With 512.55K shares outstanding, the current market capitalization sits at 762.47M.

A.I. Advisor

published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

500 Unicorn Park Drive

Phone

+1 781 222-9600

Employees

284

Web

https://www.replimune.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	23.14	-0.28	-1.20%
GameStop Corp
TSLA	210.60	-3.51	-1.64%
Tesla
SPY	552.08	-11.60	-2.06%
SPDR® S&P 500® ETF Trust
AAPL	222.77	-6.23	-2.72%
Apple
BTC.X	57431.023000	-1681.457000	-2.84%
Bitcoin cryptocurrency

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with SWTX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then SWTX could also see price increases.

Ticker / NAME	Correlation To REPL	1D Price Change %
REPL	100%	+1.08%
SWTX - REPL	34% Loosely correlated	-3.14%
ZYME - REPL	33% Loosely correlated	-1.79%
VIR - REPL	33% Poorly correlated	-5.81%
IBIO - REPL	32% Poorly correlated	-4.57%
CHRS - REPL	31% Poorly correlated	-2.16%
More

Groups containing REPL

Correlation & Price change

Ticker / NAME	Correlation To REPL	1D Price Change %
REPL	100%	+1.08%
immunotherapy theme (13 stocks)	39% Loosely correlated	-0.95%
cancer theme (87 stocks)	35% Loosely correlated	+0.89%
drugs theme (265 stocks)	33% Poorly correlated	+5.37%
biotechnology theme (248 stocks)	31% Poorly correlated	+5.56%